IpiNovyx Bio
We are a drug platform focused on treating autoimmune and inflammatory diseases.
6 employees · est. 2021 · United States
VentiRx Pharmaceuticals
Advancing healthcare innovations with targeted therapies for cancer, respiratory, and autoimmune diseases.
est. 2006
VentiRx Pharmaceuticals is the older company (2021 vs 2006).
Side-by-Side Comparison
| Metric | IpiNovyx Bio | VentiRx Pharmaceuticals |
|---|---|---|
| Founded | ||
| Founded | 2021 | 2006 older |
| Headquarters | ||
| Headquarters | United States | Not tracked yet |
| Employees | ||
| Employees | 6 | Not tracked yet |
| Industry | ||
| Industry | Biopharma, Biotechnology, Health Care | Biotechnology, Health Care, Health and Wellness |
| Funding Stage | ||
| Funding Stage | Seed | Series B |
| Total Funding | ||
| Total Funding | $10.00M | $104.50M |
| Funding Rounds | ||
| Funding Rounds | 2 | 4 |
| Services | ||
| Services | Not tracked yet | Not tracked yet |
| Target Customers | ||
| Target Customers | Not tracked yet | Not tracked yet |
| Taxonomy | ||
| Taxonomy | Autoimmune Diseases, Inflammatory Diseases, Biopharmaceuticals, Small Molecule Therapeutics, Immunoproteasome Modulation, Immunoproteasome Inhibitors, Selective Drug Targeting, Immune Cell Modulation, Selective Inhibition, Therapeutic Development, Precision Medicine, Drug Discovery, Clinical Validation, Biotechnology Innovations, Healthcare Advancement | Biopharmaceutical, Clinical-stage, Cancer Treatment, Respiratory Diseases, Autoimmune Diseases, Small Molecule Therapies, TLR8 Agonists, TLR8 Antagonists, Vaccine Adjuvants, Oncology, Allergy Treatment, Immune Response Stimulation, Celgene Corporation Collaboration, Seattle Headquarters, San Diego Operations |
| Website | ||
| Website | ipinovyxbio.com | ventirx.com |
About IpiNovyx Bio
IpiNovyx Bio, founded in 2021, is a promising startup in the Biopharma and Biotechnology sectors, with a specific focus on Health Care. The company is headquartered in the United States. Embodying the slogan, "We are a drug platform focused on treating autoimmune and inflammatory diseases," IpiNovy...
About VentiRx Pharmaceuticals
VentiRx Pharmaceuticals is a clinical-stage biopharmaceutical company focused on developing targeted therapies for cancer, respiratory, and autoimmune diseases. The company's product pipeline includes VTX-2337, a small molecule TLR8 agonist designed to stimulate myeloid dendritic cells and monocytes...
We will tell you when either one moves
BounceWatch watches IpiNovyx Bio and VentiRx Pharmaceuticals for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at IpiNovyx Bio and VentiRx Pharmaceutical... — by email.
Frequently Asked Questions
Compare IpiNovyx Bio with someone else
Start typing a company name or domain.
Related Comparisons
Compiled from the BounceWatch company index. We last looked at IpiNovyx Bio on 11 Mar 2026, and VentiRx Pharmaceuticals on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.